Indication
Serratia peritonitis
Serratia peritonitis is an uncommon, severe bacterial infection and inflammation of the peritoneal cavity caused by species of the Gram-negative opportunistic bacillus *Serratia*, most frequently *Serratia marcescens*. Read more about Serratia peritonitis
7 drugs 7 manufacturers
Drugs that treat it
Common Serratia peritonitis therapies.
AZTREONAM
AZTREONAM
AZTREONAM
AZTREONAM
AZTREONAM
AZTREONAM
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSerratia peritonitis is an uncommon, severe bacterial infection and inflammation of the peritoneal cavity caused by species of the Gram-negative opportunistic bacillus *Serratia*, most frequently *Serratia marcescens*.
It predominantly affects individuals receiving peritoneal dialysis or hospitalized, immunocompromised patients with indwelling abdominal catheters or invasive abdominal procedures.
Pathophysiologically, the organism colonizes peritoneal catheter access sites or the lumen, forming resilient biofilms and producing inducible beta-lactamases that impair antimicrobial efficacy.
Clinically, it manifests with cloudy dialysate effluent rich in neutrophilic leukocytes, acute abdominal pain, rebound tenderness, nausea, and systemic fever, frequently carrying an elevated risk of treatment failure, relapse, and dialysis catheter loss compared to Gram-positive peritonitis.
- nih.gov
Serratia peritonitis is an uncommon, severe bacterial infection and inflammation of the peritoneal cavity caused by species of the Gram-negative opportunistic bacillus *Serratia*, most frequently *Serratia marcescens* It predominantly affects individuals receiving peritoneal dialysis or hospitalized, immunocompromised patients with indwelling abdominal catheters or invasive abdominal procedures Clinically, it manifests with cloudy dialysate effluent rich in neutrophilic leukocytes, acute abdomin...
- ovid.com
Serratia peritonitis is an uncommon, severe bacterial infection and inflammation of the peritoneal cavity caused by species of the Gram-negative opportunistic bacillus *Serratia*, most frequently *Serratia marcescens* Clinically, it manifests with cloudy dialysate effluent rich in neutrophilic leukocytes, acute abdominal pain, rebound tenderness, nausea, and systemic fever, frequently carrying an elevated risk of treatment failure, relapse, and dialysis catheter loss compared to Gram-positive pe...
- clevelandclinic.org
It predominantly affects individuals receiving peritoneal dialysis or hospitalized, immunocompromised patients with indwelling abdominal catheters or invasive abdominal procedures
- nih.gov
Pathophysiologically, the organism colonizes peritoneal catheter access sites or the lumen, forming resilient biofilms and producing inducible beta-lactamases that impair antimicrobial efficacy Clinically, it manifests with cloudy dialysate effluent rich in neutrophilic leukocytes, acute abdominal pain, rebound tenderness, nausea, and systemic fever, frequently carrying an elevated risk of treatment failure, relapse, and dialysis catheter loss compared to Gram-positive peritonitis
- researchgate.net
Pathophysiologically, the organism colonizes peritoneal catheter access sites or the lumen, forming resilient biofilms and producing inducible beta-lactamases that impair antimicrobial efficacy
- nih.gov
Clinically, it manifests with cloudy dialysate effluent rich in neutrophilic leukocytes, acute abdominal pain, rebound tenderness, nausea, and systemic fever, frequently carrying an elevated risk of treatment failure, relapse, and dialysis catheter loss compared to Gram-positive peritonitis
Personalize your experience
Follow Serratia peritonitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.